))
Empowered Patient Podcast with Karen Jagoda is a window into the latest innovations in digital health, the changing dynamic between doctors and patients, and the emergence of precision medicine. The show covers such topics as aging in place, innovative uses for wearables and sensors, advances in clinical research, applied genetics, drug development, and challenges for connected health entrepreneurs.
…
continue reading
mHealth Zone Live is an Internet radio show that discusses the latest in mobile health and technology and interviews industry experts. Whether you’re a healthcare provider, professional, patient, or developer, mHealth Zone Live will help you navigate the exciting world of mobile health. Join the conversation using hashtag #mHealthZone.
…
continue reading
All things health & healthcare innovation. Often provocative, sometimes funny, & always entertaining.
…
continue reading
Conversational technology and patient engagement are two technology trends sweeping through the three trillion dollar healthcare industry. In these short, interactive discussions, industry experts talk about how and where innovation is impacting the customer experience at hospitals, pharmaceutical companies, and the vast array of related services in the industry.
…
continue reading
Stephen Hays is a recovering addict, living with type-1 bipolar disorder. He spent years living in addiction, and with untreated mental illness while he went from West Point graduate, to Wall Street Banker to nearly taking his own life when he hit bottom. On this show you will hear stories of addiction, mental illness, recovery, hope, and wellness. You will also hear from clinicians, experts, doctors, entrepreneurs and others who are trying to lead other people to wellness. We would love to ...
…
continue reading
1
The Health Crossroad with Dr. Doug Elwood and Dr. Tom Elwood
Dr. Doug Elwood and Dr. Tom Elwood Presenting A Leading Podcast on Health, Business, and Leadership with Amazing Featured Guests From Around Health
Health care is currently at a crossroad. It represents 18 percent of GDP in the United States, the largest economy in the world, and faces multiple challenges but with many opportunities for improvement. Health permeates the life of every individual in some form or fashion. The Health Crossroad explores this world. We invite you to listen and participate, both on our podcast and our accompanying website, where we will post summaries and key concepts from each interview as well as advice and ...
…
continue reading
1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis TRANSCRIPT
Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …
…
continue reading
1
Impact of AI on Reducing Waste and Friction in Healthcare Administration with Joan Butters Xsolis
16:07
16:07
Play later
Play later
Lists
Like
Liked
16:07
Joan Butters, CEO and Co-Founder of Xsolis works with health systems and health plans to automate medical necessity decisions and improve efficiency. Using data and AI, Xsolis helps clinicians make more informed decisions and reduces manual administrative work, resulting in time and cost savings and improved patient care. Addressing the challenges …
…
continue reading
1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics TRANSCRIPT
Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…
…
continue reading
1
Cancer Molecular Profiling Using Next-Generation Sequencing to Treat Rare Diseases with Sanjeev Redekar Apollomics
17:45
17:45
Play later
Play later
Lists
Like
Liked
17:45
Sanjeev Redkar, Co-Founder, Executive Director, and President of Apollomics, focuses on difficult-to-treat cancers, such as lung cancer, brain cancer, and leukemias, not served by immune checkpoint inhibitors. Their approach targets the thematic pathway in cancer cells responsible for their growth and proliferation. In their drug development, AI an…
…
continue reading
Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …
…
continue reading
1
Redefining Healthcare for Women Over 65 with Kristen Helton Herself Health
19:07
19:07
Play later
Play later
Lists
Like
Liked
19:07
Kristen Helton, CEO and Co-Founder of Herself Health, provides comprehensive primary care designed specifically for women over 65, considering the unique health challenges these women face. The emphasis is on the importance of addressing women's health beyond reproductive health and the need for tailored treatment and screening for conditions that …
…
continue reading
1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics TRANSCRIPT
Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…
…
continue reading
1
Modifying Macrophages to Overcome Evasion by Cancer Cells and Educate Immune System with Robert Towarnicki SIRPant Immunotherapeutics
24:52
24:52
Play later
Play later
Lists
Like
Liked
24:52
Robert Towarnicki, CEO and Co-founder of SIRPant Immunotherapeutics, discusses cancer-specific immunotherapy for aggressive tumors, the role macrophages play in the immune response to cancer, and how cancer cells can shut down this response. SIRPant Immunotherapeutics aims to modify macrophages by reducing SIRPα expression, triggering them to eat c…
…
continue reading
1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix TRANSCRIPT
Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…
…
continue reading
1
Power of AI and Data Analytics to Improve Patient Safety Risk Management with Jeff Surges RLDatix
17:39
17:39
Play later
Play later
Lists
Like
Liked
17:39
Jeff Surges, CEO of RLDatix, offers global cloud-based solutions for risk management, compliance management, and regulatory management in healthcare. To address patient safety, Jeff emphasizes the need for a collaborative workforce, data analytics, and AI. RLDatix uses technology to automate information gathering, facilitate incident reporting, and…
…
continue reading
1
Tailoring Diabetes Management Using Hybrid Closed-Loop Algorithm to Meet Individual Needs with Lou Lintereur Medtronic Diabetes TRANSCRIPT
Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA to developing technology for those living with diabetes. He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose monitor (CGM) with a control algori…
…
continue reading
1
Tailoring Diabetes Management Using Hybrid Closed-Loop Algorithm to Meet Individual Needs with Lou Lintereur Medtronic Diabetes
20:01
20:01
Play later
Play later
Lists
Like
Liked
20:01
Lou Lintereur, Chief Engineer for automated delivery systems at Medtronic Diabetes, brought his knowledge from working as an aerospace engineer at NASA to developing technology for those living with diabetes. He introduces the MiniMed 780G, a closed-loop system that combines an insulin pump and continuous glucose monitor (CGM) with a control algori…
…
continue reading
1
Transparency in Coverage Rule Provides Precision of Price and Negotiated Rates for Healthcare with Mark Galvin TALON TRANSCRIPT
Mark Galvin, Co-Founder, President, and CEO of TALON, discusses the Transparency in Coverage rule in healthcare, which was added to the Affordable Care Act and requires commercial health plan sponsors to provide transparency in the costs of tests, procedures, and other medical services. The rule aims to provide patients with information on pricing …
…
continue reading
1
Transparency in Coverage Rule Provides Precision of Price and Negotiated Rates for Healthcare with Mark Galvin TALON
20:43
20:43
Play later
Play later
Lists
Like
Liked
20:43
Mark Galvin, Co-Founder, President, and CEO of TALON, discusses the Transparency in Coverage rule in healthcare, which was added to the Affordable Care Act and requires commercial health plan sponsors to provide transparency in the costs of tests, procedures, and other medical services. The rule aims to provide patients with information on pricing …
…
continue reading
1
Deploying Technology in Decentralized Clinical Trials Improves Recruitment and Retention with Alice Lin Tigermed Consulting TRANSCRIPT
Alice Lin, DCT Solutions Director in the DCT Business Department of Tigermed Consulting, a global CRO, contract research organization, that provides biopharmaceutical and medical device companies with a range of services including digital technology to conduct decentralized clinical trials. Their approach focuses on patient-centricity, efficiency, …
…
continue reading
1
Deploying Technology in Decentralized Clinical Trials Improves Recruitment and Retention with Alice Lin Tigermed Consulting
18:50
18:50
Play later
Play later
Lists
Like
Liked
18:50
Alice Lin, DCT Solutions Director in the DCT Business Department of Tigermed Consulting, a global CRO, contract research organization, that provides biopharmaceutical and medical device companies with a range of services including digital technology to conduct decentralized clinical trials. Their approach focuses on patient-centricity, efficiency, …
…
continue reading
1
Developing Drug Targeting B Cells in Autoimmune Disease of the Kidney IgA Nephropathy with Dr. Marshall Fordyce Vera Therapeutics TRANSCRIPT
Dr. Marshall Fordyce, CEO and Founder of Vera Therapeutics, discusses the company's patient-centric approach to developing new medicines for autoimmune diseases. Vera is currently in Phase 3 with a molecule called Atacicept, which targets B cells in autoimmune diseases. They focus on IgA nephropathy, a rare kidney disease, and the third most common…
…
continue reading
1
Developing Drug Targeting B Cells in Autoimmune Disease of the Kidney IgA Nephropathy with Dr. Marshall Fordyce Vera Therapeutics
20:09
20:09
Play later
Play later
Lists
Like
Liked
20:09
Dr. Marshall Fordyce, CEO and Founder of Vera Therapeutics, discusses the company's patient-centric approach to developing new medicines for autoimmune diseases. Vera is currently in Phase 3 with a molecule called Atacicept, which targets B cells in autoimmune diseases. They focus on IgA nephropathy, a rare kidney disease, and the third most common…
…
continue reading
Pascal Prigent, the CEO of GENFIT, a French biotech that has been working on liver diseases for about 20 years and has developed a compound called elafibranor for conditions such as primary biliary cholangitis (PBC). The company is also developing assets in acute-on-chronic liver failure (ACLF). He highlights the high unmet medical need in ACLF, wh…
…
continue reading
1
Developing Drugs to Treat Rare Liver Diseases NASH PBC ACLF with Pascal Prigent GENFIT
18:30
18:30
Play later
Play later
Lists
Like
Liked
18:30
Pascal Prigent, the CEO of GENFIT, a French biotech that has been working on liver diseases for about 20 years and has developed a compound called elafibranor for conditions such as primary biliary cholangitis (PBC). The company is also developing assets in acute-on-chronic liver failure (ACLF). He highlights the high unmet medical need in ACLF, wh…
…
continue reading
1
Research Set to Expand as Federal Government Considers Rescheduling Cannabis from Schedule I to Schedule III with Phil Johnston Johnston Associates TRANSCRIPT
Phil Johnston, President and CEO of Johnston Associates, and an advisor to EO Care, the market leader in providing clinically-guided cannabis use. Phil discusses the potential for research from the reclassification of cannabis from a Schedule I drug to a Schedule III drug. With current Federal restrictions on cannabis, research has not been conduct…
…
continue reading
1
Research Set to Expand as Federal Government Considers Rescheduling Cannabis from Schedule I to Schedule III with Phil Johnston Johnston Associates
17:43
17:43
Play later
Play later
Lists
Like
Liked
17:43
Phil Johnston, President and CEO of Johnston Associates, and an advisor to EO Care, the market leader in providing clinically-guided cannabis use. Phil discusses the potential for research from the reclassification of cannabis from a Schedule I drug to a Schedule III drug. With current Federal restrictions on cannabis, research has not been conduct…
…
continue reading
1
Preventative and Acute Treatment for Rare Genetic Disease HAE with Salome Juethner Takeda TRANSCRIPT
Salome Juethner, Senior Medical Director, Head of Rare Genetics, and Interim Head of Rare GI at Takeda, discusses HAE, hereditary angioedema, a rare genetic disorder that causes painful and unpredictable swelling attacks that can be life-threatening. Salome emphasizes the need to educate physicians to consider HAE as a potential diagnosis in childr…
…
continue reading
1
Preventative and Acute Treatment for Rare Genetic Disease HAE with Salome Juethner Takeda
18:21
18:21
Play later
Play later
Lists
Like
Liked
18:21
Salome Juethner, Senior Medical Director, Head of Rare Genetics, and Interim Head of Rare GI at Takeda, discusses HAE, hereditary angioedema, a rare genetic disorder that causes painful and unpredictable swelling attacks that can be life-threatening. Salome emphasizes the need to educate physicians to consider HAE as a potential diagnosis in childr…
…
continue reading
1
Enhancing Patient Engagement and Collaboration with Healthcare Providers with Lorie Spence and Carolyn Pritchard Bridge Medical Communications TRANSCRIPT
Lorie Spence and Carolyn Pritchard, Co-Founders of Bridge Medical Communications, focus on developing tools and resources to support healthcare professionals and patients in collaborating and making informed treatment decisions. They emphasize the importance of patient-centered care, participatory medicine, and patient engagement to help address th…
…
continue reading
1
Enhancing Patient Engagement and Collaboration with Healthcare Providers with Lorie Spence and Carolyn Pritchard Bridge Medical Communications
22:12
22:12
Play later
Play later
Lists
Like
Liked
22:12
Lorie Spence and Carolyn Pritchard, Co-Founders of Bridge Medical Communications, focus on developing tools and resources to support healthcare professionals and patients in collaborating and making informed treatment decisions. They emphasize the importance of patient-centered care, participatory medicine, and patient engagement to help address th…
…
continue reading
